Your browser doesn't support javascript.
loading
Sorafenib in Hepatopulmonary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Kawut, Steven M; Ellenberg, Susan S; Krowka, Michael J; Goldberg, David; Vargas, Hugo; Koch, David; Sharkoski, Tiffany; Al-Naamani, Nadine; Fox, Alyson; Brown, Robert; Levitsky, Joshua; Oh, Jae K; Lin, Grace; Song, Nianfu; Mottram, Carl; Doyle, Margaret F; Kaplan, David E; Gupta, Samir; Fallon, Michael B.
Afiliação
  • Kawut SM; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Ellenberg SS; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Krowka MJ; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Goldberg D; Department of Medicine, Mayo Clinic, Rochester, MN.
  • Vargas H; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Koch D; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Sharkoski T; Department of Medicine, Mayo Clinic, Phoenix, AZ.
  • Al-Naamani N; Department of Medicine, Medical University of South Carolina, Charleston, SC.
  • Fox A; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Brown R; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Levitsky J; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Oh JK; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Lin G; Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY.
  • Song N; Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY.
  • Mottram C; Department of Medicine, Northwestern University, Chicago, IL.
  • Doyle MF; Department of Medicine, Mayo Clinic, Rochester, MN.
  • Kaplan DE; Department of Medicine, Mayo Clinic, Rochester, MN.
  • Gupta S; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Fallon MB; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Liver Transpl ; 25(8): 1155-1164, 2019 08.
Article em En | MEDLINE | ID: mdl-30816637
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Síndrome Hepatopulmonar / Inibidores de Proteínas Quinases / Sorafenibe / Neovascularização Patológica Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Liver Transpl Assunto da revista: GASTROENTEROLOGIA / TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Síndrome Hepatopulmonar / Inibidores de Proteínas Quinases / Sorafenibe / Neovascularização Patológica Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Liver Transpl Assunto da revista: GASTROENTEROLOGIA / TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos